GLF
RMD icon

Groupe la Francaise’s ResMed RMD Stock Holding History

Groupe la Francaise’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19K Buy
42
+8
+24% +$1.66K ﹤0.01% 467
2026
Q1 		$7.63K Sell
34
-3
-8% -$748 ﹤0.01% 435
2025
Q4 		$8.91K Buy
37
+15
+68% +$3.84K ﹤0.01% 429
2025
Q3 		$6.02K Sell
22
-199
-90% -$54.4K ﹤0.01% 622
2025
Q2 		$57K Buy
221
+17
+8% +$4.05K ﹤0.01% 405
2025
Q1 		$45.4K Buy
+204
New +$47.6K ﹤0.01% 409

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Groupe la Francaise's RMD Position: Q2 2026 in Review

Groupe la Francaise increased its ResMed (RMD) stake by 24% in Q2 2026, buying an estimated $1.66K and bringing the position to 42 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

Groupe la Francaise first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $57K in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Groupe la Francaise held 42 shares of ResMed worth $8.19K as of Q2 2026.
  • Groupe la Francaise bought 8 ResMed shares in Q2 2026, an estimated $1.66K.
  • ResMed made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #467 holding.
  • Groupe la Francaise first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Groupe la Francaise's ResMed position peaked at $57K in Q2 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.